Understanding the real-world impact of chronic ITP requires a deep look at clinical data across various demographics. Recent Immune Thrombocytopenia Market research shows that fatigue is one of the most underreported yet debilitating symptoms for patients. Researchers are now prioritizing the inclusion of Patient-Reported Outcome (PRO) measures in clinical trials to ensure that new drugs don't just fix platelet counts, but also improve overall energy levels and mental health.

FAQ

• Why is fatigue common in ITP patients? Fatigue is often linked to the inflammatory nature of the autoimmune response, rather than just the low platelet count itself.

• How is ITP diagnosed? It is typically a "diagnosis of exclusion," meaning doctors rule out other causes of low platelets (like leukemia or infections) before confirming ITP.